About ABEO

PlasmaTech Biopharmaceuticals is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. PlasmaTech's lead program is a gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. In addition, the company is pursuing two additional proprietary platforms, Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT), and is active in the development and commercialization of human plasma-derived therapeutics, including its proprietary alpha-1 protease inhibitor, SDF Alpha. The company has developed a robust product pipeline that includes two commercial stage products, MuGard and ProctiGard, with additional follow-on products in development.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ABEO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
URTY ProShares UltraPro Russell2000 91.1 M 9.11375E+07 2,007 2007 0.0% 1.17536E-05 3 K 3479
UWM ProShares Ultra Russell2000 159.0 M 1.58953E+08 2,006 2006 0.0% 1.96859E-05 7 K 6767
ITOT iShares Core S&P Total U.S. Stock Market ETF 22.8 B 2.28238E+10 3,537 3537 0.0% 0 61 K 60859
VHT Vanguard Health Care ETF 9.1 B 9.1E+09 388 388 0.0% 2.13381E-05 194 K 194160
IWC iShares Microcap ETF 833.3 M 8.33271E+08 1,383 1383 0.03% 0.0003 246 K 246249
IWM iShares Russell 2000 ETF 45.7 B 4.56694E+10 1,995 1995 0.01% 0.0001 2.4 M 2390010
IWN iShares Russell 2000 Value ETF 9.4 B 9.42018E+09 1,388 1388 0.01% 0.0001 941 K 941485
IWV iShares Russell 3000 ETF 9.7 B 9.71439E+09 2,895 2895 0.0% 0 24 K 23643
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 370 370 0.0% 2.62436E-05 39 K 38872
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.0% 8.18217E-07 2 K 1739